Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

Fragile X syndrome (FXS) is associated with behavior that limits functioning, including distractibility, hyperactivity, impulsivity, hyperarousal, anxiety, mood dysregulation, and aggression. Medication response and side effect data were reviewed retrospectively for 257 patients (age 14±11 years, ra...

Full description

Bibliographic Details
Main Authors:	Elizabeth Berry-Kravis, Allison Sumis, Crystal Hervey, Shaguna Mathur
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	International Journal of Pediatrics
Online Access:	http://dx.doi.org/10.1155/2012/843016

Similar Items

Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
by: Knox Andrew, et al.
Published: (2012-02-01)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
by: Anna W. Lee, et al.
Published: (2018-12-01)

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
by: Debra L. Reisinger, et al.
Published: (2020-04-01)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
by: Skylar Luu, et al.
Published: (2020-09-01)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
by: Dejan B. Budimirovic, et al.
Published: (2017-06-01)

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome.
by: David Hessl, et al.
Published: (2019-01-01)

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment
by: Anne Hoffmann, et al.
Published: (2020-04-01)

Open-label add-on treatment trial of minocycline in fragile X syndrome
by: Tranfaglia Michael, et al.
Published: (2010-10-01)

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
by: Jayne Dixon Weber, et al.
Published: (2019-01-01)

Vocabulary comprehension in adults with fragile X syndrome (FXS)
by: Anne Hoffmann, et al.
Published: (2019-10-01)

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
by: Deborah A Hall, et al.
Published: (2020-01-01)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
by: Avram eFraint, et al.
Published: (2014-10-01)

Best Practices in Fragile X Syndrome Treatment Development
by: Craig A. Erickson, et al.
Published: (2018-12-01)

Arbaclofen in fragile X syndrome: results of phase 3 trials
by: Berry-Kravis, Elizabeth, et al.
Published: (2017)

Arbaclofen in fragile X syndrome: results of phase 3 trials
by: Elizabeth Berry-Kravis, et al.
Published: (2017-06-01)

Child and adolescent clinical psychopharmacology
by: Rubens Reimão
Published: (1997-06-01)

Síndrome frágil X Fragile X Syndrome
Published: (2007-03-01)

Síndrome frágil X Fragile X syndrome
by: Miguel Lugones Botell, et al.
Published: (2006-09-01)

Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome
by: Marika C. Coffman, et al.
Published: (2020-04-01)

Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
by: Erin E. Robertson, et al.
Published: (2020-01-01)

Teachers and Psychopharmacology
by: J Gordon Millichap
Published: (1988-04-01)

Psychopharmacology of Addiction
by: Tugce Toker Ugurlu, et al.
Published: (2012-03-01)

Fragile X Syndrome
by: J Gordon Millichap
Published: (1987-11-01)

Fragile-X Syndrome
by: J Gordon Millichap
Published: (1988-03-01)

Fragile X Syndrome
by: Ninlapa Pruksanusak, et al.
Published: (2012-06-01)

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
by: Randi Hagerman, et al.
Published: (2018-11-01)

Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
by: James R. Brašić, et al.
Published: (2020-11-01)

A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
by: Tovi Anderson, et al.
Published: (2013-01-01)

Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype.
by: Stephen C Collins, et al.
Published: (2010-03-01)

The Fragile X Syndrome: Behavioral Phenotype and Learning Disabilities
by: Claudia GRAU RUBIO, et al.
Published: (2016-04-01)

Clinical, biological and psychopharmacological studies in depressive illness
by: Abou-Saleh, M. T.
Published: (1985)

Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome
by: Cara J. Westmark, et al.
Published: (2020-10-01)

Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome
by: Emanuele Sinagra, et al.
Published: (2012-01-01)

Health Profiles of Mosaic Versus Non-mosaic FMR1 Premutation Carrier Mothers of Children With Fragile X Syndrome
by: Marsha R. Mailick, et al.
Published: (2018-05-01)

Utility of the Hebb–Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans
by: Isabelle Boutet, et al.
Published: (2018-03-01)

Neuroanatomy of Fragile X Syndrome
by: J Gordon Millichap
Published: (1991-02-01)

Epilepsy and Fragile X Syndrome
by: J Gordon Millichap
Published: (2003-01-01)

Diagnosis of Fragile X Syndrome
by: J Gordon Millichap
Published: (1991-12-01)

Fragile X Syndrome Recognition
by: J Gordon Millichap
Published: (1989-02-01)

Screening for fragile X syndrome.
by: Murray, et al.
Published: (1997-01-01)

Cannot write session to /tmp/vufind_sessions/sess_pavelkeolgkehld44fgn9ni1a1